• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性肝炎肝硬化合并肝细胞癌患者经动脉化疗栓塞术后肿瘤破裂

Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma.

作者信息

Gala Khushboo, Guardiola-Bright John, McGee Suzanne

机构信息

Internal Medicine, University of Louisville Hospital, Louisville, USA.

Internal Medicine, University of Louisville, Louisville, USA.

出版信息

Cureus. 2020 Apr 20;12(4):e7750. doi: 10.7759/cureus.7750.

DOI:10.7759/cureus.7750
PMID:32455067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7243093/
Abstract

Transarterial chemoembolization (TACE) is a generally well-tolerated and safe procedure that is increasingly being used in the management of intermediate-stage hepatocellular carcinoma (HCC). Tumor rupture is a rare major complication of TACE. Predisposing factors for tumor rupture include large tumor size and peripherally located tumors; in cases of HCC in cirrhosis secondary to autoimmune hepatitis (AIH), tumor rupture may occur more frequently because of the phenomenon of peliosis that occurs in AIH leading to higher propensity to rupture. Management of tumor rupture can be surgical or conservative depending on the individual case. We describe the first documented case of tumor rupture post-TACE in a patient with AIH cirrhosis and HCC.

摘要

经动脉化疗栓塞术(TACE)是一种耐受性良好且安全的手术,越来越多地用于中期肝细胞癌(HCC)的治疗。肿瘤破裂是TACE罕见的严重并发症。肿瘤破裂的诱发因素包括肿瘤体积大及肿瘤位于周边;在自身免疫性肝炎(AIH)继发肝硬化的HCC病例中,由于AIH中发生的紫癜现象导致更高的破裂倾向,肿瘤破裂可能更频繁发生。根据具体病例,肿瘤破裂的处理可以是手术治疗或保守治疗。我们描述了首例有记录的AIH肝硬化合并HCC患者TACE术后肿瘤破裂的病例。

相似文献

1
Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma.自身免疫性肝炎肝硬化合并肝细胞癌患者经动脉化疗栓塞术后肿瘤破裂
Cureus. 2020 Apr 20;12(4):e7750. doi: 10.7759/cureus.7750.
2
Hepatocellular carcinoma rupture following transarterial chemoembolization.经动脉化疗栓塞术后肝细胞癌破裂
Semin Intervent Radiol. 2015 Mar;32(1):49-53. doi: 10.1055/s-0034-1396964.
3
Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding.经动脉化疗栓塞术后肝细胞癌破裂并继以大量胃出血
Case Reports Hepatol. 2018 Jun 4;2018:4576276. doi: 10.1155/2018/4576276. eCollection 2018.
4
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.经动脉化疗栓塞术在肝细胞癌治疗中的应用:巴塞罗那临床肝癌分期系统
World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327.
5
Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report.肝细胞癌经动脉化疗栓塞术后发生缺血性十二指肠溃疡:一例报告
Case Rep Gastroenterol. 2018 Jun 28;12(2):352-359. doi: 10.1159/000490604. eCollection 2018 May-Aug.
6
Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.经动脉化疗栓塞单药治疗与经动脉化疗栓塞-微波消融联合治疗≤5厘米肝细胞癌肿瘤的疗效比较:单中心倾向分析
Cardiovasc Intervent Radiol. 2017 Nov;40(11):1748-1755. doi: 10.1007/s00270-017-1736-8. Epub 2017 Jul 5.
7
Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.经肝动脉化疗栓塞术治疗后,介入治疗后白细胞介素 6(IL-6)水平而非治疗前或 IL-6 的动态变化,可作为肝细胞癌早期肿瘤反应的实用标志物。
Oncologist. 2019 Dec;24(12):e1489-e1495. doi: 10.1634/theoncologist.2018-0669. Epub 2019 Jun 27.
8
Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.索拉非尼联合经动脉化疗栓塞治疗BCLC B期肝细胞癌的总生存期:倾向评分分析
Int J Clin Pharmacol Ther. 2017 Jun;55(6):498-508. doi: 10.5414/CP202787.
9
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.经动脉单纯栓塞与化疗栓塞治疗肝细胞癌:重新审视金标准
J Surg Res. 2016 Feb;200(2):552-9. doi: 10.1016/j.jss.2015.09.034. Epub 2015 Oct 3.
10
Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report.经动脉化疗栓塞术后肝细胞癌破裂并腹腔内出血:一例报告
Cases J. 2009 Jan 20;2(1):68. doi: 10.1186/1757-1626-2-68.

引用本文的文献

1
A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature.经动脉化疗栓塞术后罕见的早期致命并发症:病例报告及文献复习。
Curr Oncol. 2024 Apr 3;31(4):1961-1970. doi: 10.3390/curroncol31040147.
2
Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?破裂性肝细胞癌:介入放射科医生需要了解什么?
Front Oncol. 2022 Jun 16;12:927123. doi: 10.3389/fonc.2022.927123. eCollection 2022.

本文引用的文献

1
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.根据肝硬化的病因,肝癌风险、预测因素和随时间变化的趋势存在差异。
PLoS One. 2018 Sep 27;13(9):e0204412. doi: 10.1371/journal.pone.0204412. eCollection 2018.
2
Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors.经动脉化疗栓塞术(TACE)治疗肝肿瘤的并发症。
Cir Esp (Engl Ed). 2018 Nov;96(9):560-567. doi: 10.1016/j.ciresp.2018.06.004. Epub 2018 Aug 3.
3
Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding.
经动脉化疗栓塞术后肝细胞癌破裂并继以大量胃出血
Case Reports Hepatol. 2018 Jun 4;2018:4576276. doi: 10.1155/2018/4576276. eCollection 2018.
4
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.自身免疫性肝炎中肝细胞癌的发病率及决定因素:一项系统评价与荟萃分析
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1207-1217.e4. doi: 10.1016/j.cgh.2017.02.006. Epub 2017 Feb 12.
5
The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.肝细胞癌传统经动脉栓塞化疗(TAE/TACE)后主要并发症的发生率及结局
Medicine (Baltimore). 2016 Dec;95(49):e5606. doi: 10.1097/MD.0000000000005606.
6
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.经动脉化疗栓塞术在肝细胞癌治疗中的应用:巴塞罗那临床肝癌分期系统
World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327.
7
Transarterial chemoembolization: modalities, indication, and patient selection.经动脉化疗栓塞:方式、适应证和患者选择。
J Hepatol. 2015 May;62(5):1187-95. doi: 10.1016/j.jhep.2015.02.010. Epub 2015 Feb 12.
8
Ruptured hepatic carcinoma after transcatheter arterial chemoembolization.经导管动脉化疗栓塞术后肝癌破裂
Curr Ther Res Clin Exp. 2013 Jun;74:41-3. doi: 10.1016/j.curtheres.2012.12.006.
9
Epidemiology of hepatocellular carcinoma: consider the population.肝细胞癌的流行病学:从人群角度考虑。
J Clin Gastroenterol. 2013 Jul;47 Suppl(0):S2-6. doi: 10.1097/MCG.0b013e3182872f29.
10
Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.肝细胞癌自发破裂的预测因素和临床结局。
World J Gastroenterol. 2012 Dec 28;18(48):7302-7. doi: 10.3748/wjg.v18.i48.7302.